Erol Hüseyin Aksungur

Purpose: To investigate the influence of sarcopenia on the outcomes of endovascular treatment in patients with pelvic venous insufficiency (PVI). Material and Methods: A retrospective analysis was conducted on 62 female patients who underwent endovascular treatment for PVI between January 2012 and July 2020. The patients were evaluated using the Visual Analog Scale (VAS) for chronic pelvic pain, both before treatment and three months post-treatment. A successful treatment outcome was defined as a reduction in pelvic pain by 50% or more. Sarcopenia was diagnosed based on the skeletal muscle mass index (SMI) of the patients. Results: Sarcopenia was present in 20 (32.3%) patients. There was no significant difference in preprocedural VAS scores between sarcopenic and non-sarcopenic patients (36.2 ± 16.9 vs. 34.9 ± 16.1, p = 0.781). However, non-sarcopenic patients achieved a significantly greater reduction in VAS scores post-treatment (67.6 ± 22.4% vs. 53.1 ± 24.4%, p = 0.025). A moderate negative correlation was observed between sarcopenia and successful treatment outcomes (r = -0.365, p = 0.004). Conclusion: Sarcopenia negatively impacts the effectiveness of endovascular treatment in patients with PVI. Graphical

Background: There is no consensus on the duration of dual antiaggregant therapy after carotid stenting. This study aimed to evaluate the early contribution of dual antiaggregant therapy for three or six months to stent restenosis. Objective: This study aimed to identify the correlation between stent restenosis and the duration of dual antiplatelet therapy (DAPT) in carotid artery stenting (CAS) subjects by retrospectively scanning a CAS procedure dataset. Methods: Patients who underwent a CAS procedure received dual DAPT (acetylsalicylic acid (ASA) + clopidogrel) were recruited for this study. The first group was the patients who received dual antiaggregants for three months, and the second group was the patients who received dual antiaggregants for six months. Patients' demographic characteristics, comorbidities, and radiological results were reviewed. Follow-up activities for the following six months were assessed for stent status, complications, and new ischemic lesions. Results: A total of 65 patients received ASA (acetylsalicylic acid) + clopidogrel for six months, while the remaining 118 patients were treated for three months. The restenosis rates were not significantly different between the two groups. The complication and adverse event frequencies were also similar. Conclusion: This study revealed that the efficacy of 3-month and 6-month DAPT is similar regarding the restenosis frequency, and there are no significant differences in complication frequency.

SUMMARY: We present a rare case of a complication of placement of a carotid artery stent represented by partial opening of a carotid Wallstent caused by displacement of its metal ring marker, which thus hindered complete expansion of the stent. An intraluminally locked carotid stent necessitated referral of the patient for urgent carotid endarterectomy. A possible reason of this unusual complication can be a manufacturing defect, which, to our knowledge, was not documented previously in open public data bases or on the Internet.